Skip to main content

ProShares UltraPro Nasdaq Biotechnology

Open-end / ETF
Registrant
ProShares Trust
Net Assets
$20,225,268
Holdings
225
Latest Report
Feb 29, 2020

Holdings · 225

Export CSV
Showing 1–50 of 225 holdings by value · page 1 of 5
Holding Balance Value % of Fund Open
—
2,986 $707,896 3.50%
Alexion Pharmaceuticals, Inc.
5,131 $482,468 2.39%
Seattle Genetics, Inc.
3,974 $452,480 2.24%
Mylan NV
11,967 $205,713 1.02%
TFDXX LEX BLACKROCK FED FUND
173,710 $173,710 0.86%
Novocure Ltd.
2,295 $166,961 0.83%
Syneos Health, Inc.
2,406 $152,420 0.75%
Jazz Pharmaceuticals plc
1,312 $150,329 0.74%
Horizon Therapeutics plc
4,343 $148,617 0.73%
Ascendis Pharma A/S
1,062 $138,464 0.68%
PRA Health Sciences, Inc.
1,467 $138,191 0.68%
Repurchase Agreement
126,986 $126,986 0.63%
Reata Pharmaceuticals, Inc.
639 $124,445 0.62%
Amarin Corp. plc
8,217 $120,543 0.60%
Acceleron Pharma, Inc.
1,231 $105,780 0.52%
China Biologic Products Holdings, Inc.
891 $102,795 0.51%
Bluebird Bio, Inc.
1,283 $92,799 0.46%
Global Blood Therapeutics, Inc.
1,396 $89,288 0.44%
Nektar Therapeutics
4,079 $84,884 0.42%
FibroGen, Inc.
2,024 $84,603 0.42%
Mirati Therapeutics, Inc.
915 $81,883 0.40%
Alkermes plc
3,650 $76,066 0.38%

Showing the top 50 of 225 holdings. Create a free account to see every holding and download the CSV.